tionship between production of abnormal COL IV chains and COL4A3/COL4A4 mutations: From familial hematuria to audominant expression of a continuous spectrum of phenotypes, tosomal-dominant or recessive Alport syndrome.
COL4A5 mutations were included with typical cases of autosomal recessive ATS to secure a better definition of the phenoBarker et al [1] and several subsequent studies have type spectrum.
detected COL4A5 mutations in 50 to 60% of cases [2, Results. We identified seven previously undescribed COL4A3 3; reviewed in 4], and in 85 to 90% with more sensitive with autosomal-dominant ATS (MIM # 104200) that had
Conclusions. This study extends the mutation spectrum of been previously linked to the COL4A3/COL4A4 locus COL4A3 and COL4A4 genes, and suggests a possible rela- [12, 13] . We now report detection of eight novel mutations in six out of 36 Italian families in a comprehensive 1 I.L. and P.P. equally contributed to this work. mutation screening of COL4A3 and COL4A4.
Thirty-six probands were selected who either had a defined or possible ATS diagnosis and negative mutation probands, both belonging to the group of autosomalrecessives, whereas in four probands (one autosomaldominant, two sporadic and one adopted), there was only one mutated allele in heterozygous state. Figure 1 shows analysis of COL4A5 [3] ( Table 1) . Twelve appeared to have autosomal-recessive ATS, six exhibited apparent the phenotype and mutation status of the six families. autosomal-dominant inheritance with father-to-son trans-COL4A3 changes mission, and 18 were sporadic cases. Consanguinity was present in two families. Average age of progression to Proband PAR is a compound heterozygote for a nonend-stage renal disease (ESRD) was 24.2 years in those sense mutation (R1037X) and a ATG→TTG change in with autosomal-recessive ATS, and 39 years in those the start codon, which probably precludes the synthewith autosomal-dominant ATS. Hearing loss was present sis of alpha3(IV) chain (Figs. 1 and 2; Table 2 ). She in 17 of 36 probands.
is a 14-year-old girl with microhematuria, proteinuria, chronic renal failure (CRF; blood creatinine 1.5 mg%) Molecular analysis and deafness. At one year of age she had an episode All the COL4A3 and COL4A4 exons were amplified of macrohematuria. Electron microscopy of the renal using primers and polymerase chain reaction (PCR) conbiopsy performed at age three showed splitting of the ditions described by Boye et al for COL4A4 [9] and by GBM, suggesting a diagnosis of ATS. Slow progressive Heidet et al for COL4A3 [10] . For exon 39 of COL4A4, renal failure became apparent in adolescence. The fathe following new primers were used: forward 5Ј-AGT ther, now aged 40, carries the R1037X mutation and has ATTAATTCTGTTTTCCCCATT-3Ј; reverse 5Ј-GGGC persistent microhematuria, but normal renal function AAAGCATGCTACAGCTT-3Ј. The following internal (blood creatinine 1.1 mg%). The mother, aged 33, carries primers designed on exonic sequences (underlined) were the start codon mutation and does not display either used: COL4A3 gene, exon 17 reverse 5Ј-ATTACCT microhematuria or other signs of ATS. TAATGCCATATTC-3Ј, exon 25 reverse 5Ј-TTCACT Proband NCL is a genetic compound for an in-frame CCCGGAGTT-3Ј; COL4A4 gene, exons 2, 42, 44 are 27 bp deletion in exon 39 (3386del27), causing the loss in Boye et al [9] . Silver staining, single-strand conformaof nine amino acids in the collagenous domain, and for tional polymorphism (SSCP) was performed using either a frame-shift insertion (3209insA) in exon 37. She is a a Genephor apparatus (Pharmacia Amersham, Little 17-year-old girl with CRF (blood creatinine 2 mg%), Braunschweig, Germany) or vertical polyacrylamide gel bilateral mixed hearing loss and delayed growth. Microelectrophoresis (PAGE). All shifts were confirmed on a hematuria and proteinuria are reported since the age of second PCR product. Direct sequencing of the purified five months, and one episode of macrohematuria at seven PCR products was performed in both directions (PE Big months. A renal biopsy at age 13 revealed GBM thickdye terminator cycle sequencing kit) on an ABI 377A ening and splitting, suggesting a diagnosis of ATS. One Automated Sequencer and analyzed with the Genescan sister aged nine, with microhematuria (blood creatinine software. All exons where mutations or rare variants 0.4 mg%) and one macrohematuria episode at age two, were identified in one patient were determined in ten has the same compound genotype, while a dizygotic additional ATS probands and in 50 healthy controls.
co-twin is homozygous for the normal sequence. The Reference nucleotide sequences in the GDB database father, now aged 43, carries the 3386del27 mutation, were: COL4A3, 128351; COL4A4, 132673. Nucleotides shows microhematuria with some macrohematuria epiwere numbered starting from the A of the initiator cosodes, and has normal renal function (blood creatinine don, in accordance with the codified nomenclature [14] . 0.9 mg%) and normal audiogram. The mother is a nonsymptomatic carrier of the 3209insA mutation. She does RESULTS not show microhematuria or proteinuria, although she had a left nephrectomy due to hydronephrosis conseSingle-strand conformational polymorphism analysis of the 36 probands detected six pathogenic mutations, quent to stenosis of the ureteropelvic junction. An appar- ently autosomal dominant form of microhematuria segShe began to suffer from a relapsing steroid-resistant nephrotic syndrome at age two, which required immunoregates in the paternal branch of the pedigree; however, suppressive treatment up to the age of eight. Although this this unfortunately was not available for analysis (Fig. 1) .
clinical course was considered unusual for a COL(IV)-In proband COZ an in-frame deletion in exon 1 associated disorder, the early onset of proteinuria and (40del24) caused the loss of eight amino acids in the persistent microhematuria with non-nephrotic proteinsignal peptide. He is a 14-year-old boy with microhemauria at age 28 prompted a renal biopsy to be performed, turia and mild proteinuria (0.2 to 0.8 g/day) since age where electron microscopy revealed irregular thinning four. His renal function is presently normal (creatinine of the GBM. The father died at 50 and the mother at clearance 86 mL/min/1.73 m 2 ) and he has neither ocular 56 with no sign of renal disease. Her 88-year-old aunt signs nor neurosensorial deafness. The same mutation had a diagnosis of nephritis but was not biopsied, and was found in the 46-year-old father, who has had microno data are available on her relatives. and macrohematuria since childhood. He has suffered
In proband DIT we identified a nine-nucleotide delefrom mild bilateral, high-tone and probably job-induced tion (3321del9) causing the loss of a Ser-Pro-Gly trihypacusis since age 39, and has normal renal function.
peptide in the collagenous domain. She is a 32-year-old No mutation was identified (by either SSCP or sequencwoman who presented with microhematuria and proteining) in the allele inherited from the mother, who has a uria (0.7 g/day). A renal biopsy performed at age 31 normal urinalysis.
revealed short segments of thinning of the GBM and Proband GST has a heterozygous missense G1198S segmental glomerulosclerosis. At age 32 she was given change in exon 42. This mutation was absent in a control angiotensin-converting enzyme (ACE) inhibitors as antigroup of 50 healthy individuals. She is a 39-year-old proteinuric treatment. Renal function is presently norwoman with microhematuria (30 RBC/microscopic field), mal. Since she is adopted, no information is available on her relatives. proteinuria (0.4 g/day) and unimpaired renal function.
peptide. With the PSORT program (www.expasy.ch/ tools/), an extracellular location of the native protein is correctly predicted with score 0.820, while for the mutant protein this score is reduced to 0.370. For this mutation, therefore, a quantitative effect seems more likely than the qualitative effect predicted for the other in-frame mutations.
Three more COL4A3 missense changes with no clear pathogenic significance were identified (Table 3) . Two were private non-glycine substitutions in the triple-helical domain, not found even in the extended series of 46 patients nor in the 50 controls. A third variant, Q1495R, was found in the NC domain. In this case, a glutamine residue conserved in alpha3(IV) chain of several species is replaced by an ancestral arginine shared by alpha1(IV) and alpha5(IV) chains (Fig. 4) . This variant was identified in a sporadic patient and in three families where it was present in all affected relatives and some healthy ones as well (data not shown). Two synonymous and one intronic variants were present each in a single patient. Finally, we found eight common polymorphisms (Table 4), including six previously reported in a different population [7, 10] . Five affect non-glycine residues in the triple helical domain, one a glycine as well in the triple helical domain (G43R [10]), one is located in the NC, and one is synonymous.
COL4A4 changes
None of these changes are predicted to be null mutations (Tables 5, 6 and 7). A pathogenic role is likely for the G448S substitution in the triple helical domain found age 28 showed non-specific thickening and splitting of the GBM. The mutation causes the loss of a StuI restriction site, but since his father died at 66, it could only be The three in-frame deletions occurred at sites of direct analyzed in his healthy mother and brother. Both tested DNA repeats in the normal COL4A3 sequence. This may negative. Haplotype analysis showed that the normal have favored a "polymerase slippage" error (not shown).
brother received a different paternal allele (not shown). Our identified mutations are likely to have various funcThree other private missense changes were non-glytional consequences (Fig. 3) . The glycine substitution cine substitutions and their pathogenic role remains to (G1198S) and the two in-frame deletions in collagenous be established (Table 6 ). R877Q and P1257R affect the domain (3321del9 and 3386del27) are expected to protriple helical domain. The third substitution, I967V, falls duce abnormal chains that can be incorporated into abwithin the eighteenth interruption of the collagenous normal tropocollagen monomers. By contrast, the framedomain. Thirteen additional COL4A4 variants were conshift (3209insA) and stop codon (R1037X) are null mutasidered as polymorphisms. Four of these-two previtions. The same is true for the start codon mutation ously characterized by Boye et al [9] and two first reported (M1L), since the next methionine is localized in exon here-result in amino acid substitutions in the triple 11, 208 amino acids downstream, and no upstream methihelical domain, while six-comprising the GGG→GGA onine codon can be found before a stop at Ϫ16. Finally, polymorphism at codon 1198 in exon 39 [11]-were syna strongly reduced secretion of the protein is expected onymous changes. The other three were novel intronic polymorphisms. for the in-frame deletion (40del24) affecting the signal 
DISCUSSION
In view of these ascertainment ambiguities, we adopted rather permissive inclusion criteria in the study of autoAlport syndrome may be caused by mutations in any of somal ATS, as in our previous study of X-linked ATS three COL4A3, COL4A4, or COL4A5 genes encoding [3] . Together with cases displaying typical features of tissue-specific collagen IV chains. Since 1990 extensive recessive ATS, that is, rapidly sex-independent progresstudies of COL4A5 in the common X-linked semidomisive nephritis or parental consanguinity [8-10], we innant ATS type have characterized more than 300 mutacluded sporadic male and female patients who had tested tions and identified the genotype-phenotype correlation negative for COL4A5 mutations. All data are from the current study. In agreement with this prediction, the pattern of inherigen triple helix. This strongly supports their pathogenicity, and even suggests a dominant negative effect. The tance in these families is recessive, as mothers of PAR and NCL are asymptomatic, and the father of PAR has same mechanism can be ascribed, by analogy with the model of osteogenesis imperfecta [24, 25] , to the two misisolated microhematuria. A similar mild BFH phenotype in COL4A3 heterozygotes has been reported by Heidet sense changes affecting glycine residues in the collagenous domain of the alpha3(IV) chain in GST, and the et al [10] . A different pathogenic mechanism is likely for two in-frame deletions in the collagenous domain (DIT alpha4(IV) chain in ZIL. Since three of the four parents were already dead, inheritance could not be demonstrated. and paternal mutation in NCL), predicted to result in the synthesis of shortened but NC domain-retaining Even so, both mutations are probably dominant since no change in the second allele was detected by sequencalpha(IV) chains that may be incorporated in the colla- ing all PCR products of the relevant gene. Moreover, a progression to CRF reported in the family of autosomaldominant ATS caused by a COL4A3 mutation [13] . diagnosis of BFH was ruled out in both patients by the presence of proteinuria, which was absent in the null A tentative genotype-phenotype correlation is shown in Figure 3 . Mutations are classified in two groups exmutation carriers. If our interpretation is correct, proband ZIL is the first example of autosomal-dominant pected to either cause the production of an abnormal alpha-chain or reduce its synthesis, and operationally di-ATS caused by a COL4A4 mutation. His renal function is still preserved at age 35, in agreement with the very late vided according to whether they are present alone (prob-ably autosomal dominant), or belong to compound hetstate and their fraction in COL4A3/COL4A4 is largely unknown. erozygous genotypes (probably autosomal recessive). In recessive cases, both null-and abnormal-chain mutations
The high level of polymorphism in both autosomal genes is an additional difficulty in recognizing mutations are found, whereas the dominant inheritance seems limited to mutations predicted to result in the production by SSCP, which was not encountered in the analysis of COL4A5 on the X chromosome. Under some circumof an abnormal chain. This is in agreement with the only reported patient with autosomal-dominant ATS, who stances, however, polymorphisms even contributed to the analysis, such as by excluding extended heterozygous delehad a large in-frame deletion of the alpha 3(IV) chain, resulting from the skipping of exon 21 [13] . Although tions. The confounding occurrence of polymorphisms was partly reduced by using internal primers [9] , though this no other family with a clear autosomal-dominant inheritance and a COL(IV) mutation has been reported, Heidet excluded part of the coding sequence and some exonintron junctions. et al mentioned a father heterozygous for the G297E mutation who reached ESRD at the age of 40 [10] .
Several polymorphisms, previously noted but not sequenced in COL4A4 by Boye et al [9] , were further charIt should be noted that the phenotype severity of carriers of mutations resulting in abnormal alpha(IV) chains acterized. Of the 13 polymorphisms scattered over the entire gene, three were intronic and six resulted in synondid not clearly follow the biochemical predictions. Thus, the in-frame deletion in the signal peptide (40del24 in ymous changes. For some of them an adverse effect on splicing cannot be ruled out: for example, P1360P in family COZ), predicted to strongly reduce secretion of the protein, was associated with a severe phenotype in exon 42 may have an influence by replacing the adenine two nucleotides upstream from the splice site. Similarly, both the heterozygous father and son, which indicates autosomal dominant inheritance. In contrast with the the rare G975G variant identified in one patient may affect splicing by introducing a potential AG donor signal predicted dominant effect, one of the in-frame deletions (3386del27 in family NCL) was recessively inherited, as within exon 32 (GGGGAA→GGAGAA). The COL4A3 gene was highly polymorphic as well, but displayed a shown by the severe phenotype of the genetic compound daughter and the milder one of the heterozygous father. different pattern: only one polymorphism was synonymous, while most resulted in amino acid substitutions. Testing larger series of patients will be necessary to ascertain whether penetrance in heterozygotes indeed
Evaluating the pathogenic significance of missense changes was particularly difficult in this study. Substitumay be confined to dominant negative mutations, and whether phenotype severity (as in osteogenesis impertions of glycine residues in the collagenous domain of COL4A5 are considered as pathogenic through a domifecta [24, 25] ) correlates with the type and position of the change and/or with other interacting factor(s).
nant negative mechanism, and are the most common missense mutations in that gene. Even they, however, In view of these findings, we could reach a positive diagnosis only in six out of the 36 families. Our rate of showed less predictable effects in the autosomal collagen IV genes. Glycine changes in the alpha3(IV) and identified pathogenic mutations (11% of the alleles) is much lower than the 53% reported by Heidet et al [10] , alpha4(IV) chains have been reported both as causative mutations in autosomal recessive ATS [9, 10] and BFH though their patients were highly selected.
Identification of few mutations in this study may depend [11] , and as common non-pathogenic polymorphisms: G43R in COL4A3 [10] and G545A in COL4A4 [9] . The on both the relaxed selection criteria and limited analytical sensitivity, especially critical for autosomal ATS, where high frequency of these variants in our healthy controls shows that they should be considered as common polythe immunohistochemical testing of skin, useful in X-linked ATS [26] , is precluded by lack of expression of alpha3 morphisms. G43R may exert a mild influence on chain flexibility since it affects the first glycine of the collage-(IV) and alpha4(IV) chains in normal skin.
The fact that direct sequencing revealed two addinous domain. By contrast, six other COL4A3 variants could not be tional mutations overlooked by SSCP demonstrates that limited analytical sensitivity is to some extent responsible.
assumed to be pathogenic on biochemical grounds (Table 3), but were indirectly imputed by their absence in The same limitation also affected our previous COL4A5 screening: in a selected subset of X-linked cases the dethe controls and cosegregation with the disease, or by phylogenetic comparisons. Q1495R alters a glutamine tection rate increased from Ͻ50% obtained by SSCP [3] to about 80% after re-analysis by direct sequencing not generally conserved, but apparently specific for the alpha3(IV) chain (Fig. 4) , where it may have a particular (Zanelli, Neri and Savi, personal communication). Some kinds of mutation, that is, those in non-coding sequences structural significance related to the nearby Goodpasture epitope [28] . Its distribution in families also points to its such as introns and the promoter, will be systematically missed by any exon-scanning approach, while large delepartially penetrant pathogenicity. The two private nonglycine substitutions P1109S and D1347E affect conserved tions, which account for 5 to 15% of cases in X-linked ATS [15, 27] , will be difficult to identify in heterozygous residues in the triple helical region. D1347E has been
